# ProVIDE II Bridging Study

> **NCT06236802** · NA · ACTIVE_NOT_RECRUITING · sponsor: **ProVerum Medical** · enrollment: 40 (actual)

## Conditions studied

- BPH With Symptomatic Lower Urinary Tract Symptoms

## Interventions

- **DEVICE:** ProVee device

## Key facts

- **NCT ID:** NCT06236802
- **Lead sponsor:** ProVerum Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-03-06
- **Primary completion:** 2024-09-06
- **Final completion:** 2029-06-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06236802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06236802, "ProVIDE II Bridging Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06236802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
